Medtech Matters

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Linnea Burman, Vice President & General Manager, Enabling Technologies: Cranial & Spinal Technologies at Medtronic. She speaks about the company’s interest in Mazor Robotics and why they made the acquisition. Burman also speaks about the evolving robotic surgical landscape as well as what’s ahead for Medtronic within the space. Specifically, the following questions are addressed.    Let’s start with the significant news Medtronic made a couple years ago when they purchased Mazor. What’s the latest with that robotic surgical technology?What was it about Mazor that made it such an attractive target to Medtronic?While the Mazor is indicated for orthopedic surgery, there’s been talk of Medtronic’s initiatives for a soft tissue robotic surgical solution. Can you speak to that at all?The da Vinci aside, the soft tissue space for robotic surgery seems to be a longer d